Mild, temporary oculorespiratory syndrome
with certain trivalent influenza vaccines used in Canada.
is a newly recognized--but apparently not new--adverse event following influenza immunization, Dr.
Dubbed oculorespiratory syndrome
(ORS), the previously unrecognized and mostly mild phenomenon was linked to one manufacturer's vaccine that contained a high level of unsplit virion (Can.
is a newly recognized but apparently not new--adverse event after influenza immunization, Dr.
Ten reports met screening criteria for oculorespiratory syndrome
, which is similar to allergic conjunctivitis but appeared within 24 hours of immunization.